Optimal treatment for OCD (OTO): A randomised controlled feasibility trial comparing the clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder.

Solange Wyatt; Naomi Fineberg; Karen Irvine; David Wellsted; David Baldwin; Lynne  Drummond; Jasmin Hanson; Srin Gopi; Sukhwinder  Kaur; Jemma Reid; Virender  Marwah; Ricky Sachdev; Ilenia  Pampaloni; Sonia Shahper; Yana Varlakova; Davis Mpavaenda; Chris Manson; Cliodhna  O'Leary; Deela Monji-Patel; A Shodunke; Anthony Dyer; Garry Barton; Amy  Dymond

Optimal treatment for OCD (OTO): A randomised controlled feasibility trial comparing the clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder.

Solange Wyatt, Naomi Fineberg, Karen Irvine, David Wellsted, David Baldwin, Lynne Drummond, Jasmin Hanson, Srin Gopi, Sukhwinder Kaur, Jemma Reid, Virender Marwah, Ricky Sachdev, Ilenia Pampaloni, Sonia Shahper, Yana Varlakova, Davis Mpavaenda, Chris Manson, Cliodhna O'Leary, Deela Monji-Patel, A ShodunkeAnthony Dyer, Garry Barton, Amy Dymond

Research output: Contribution to conference › Poster

64 Downloads (Pure)

Original language	English
Publication status	Accepted/In press - 2017
Event	European Conference on Neuropsychopharmacology - Paris, France Duration: 2 Sept 2017 → 5 Sept 2017 Conference number: 30

Conference

Conference	European Conference on Neuropsychopharmacology
Abbreviated title	ECNP
Country/Territory	France
City	Paris
Period	2/09/17 → 5/09/17

Access to Document

Final results poster ICOCS ECNP 2017Final published version, 170 KB

Cite this

Wyatt, S., Fineberg, N., Irvine, K., Wellsted, D., Baldwin, D., Drummond, L., Hanson, J., Gopi, S., Kaur, S., Reid, J., Marwah, V., Sachdev, R., Pampaloni, I., Shahper, S., Varlakova, Y., Mpavaenda, D., Manson, C., O'Leary, C., Monji-Patel, D., ... Dymond, A. (Accepted/In press). Optimal treatment for OCD (OTO): A randomised controlled feasibility trial comparing the clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder.. Poster session presented at European Conference on Neuropsychopharmacology, Paris, France.

Wyatt, Solange ; Fineberg, Naomi ; Irvine, Karen et al. / Optimal treatment for OCD (OTO): A randomised controlled feasibility trial comparing the clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder. Poster session presented at European Conference on Neuropsychopharmacology, Paris, France.

@conference{877918f1f3e44f099dc2006cef2d7e07,

title = "Optimal treatment for OCD (OTO): A randomised controlled feasibility trial comparing the clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder.",

author = "Solange Wyatt and Naomi Fineberg and Karen Irvine and David Wellsted and David Baldwin and Lynne Drummond and Jasmin Hanson and Srin Gopi and Sukhwinder Kaur and Jemma Reid and Virender Marwah and Ricky Sachdev and Ilenia Pampaloni and Sonia Shahper and Yana Varlakova and Davis Mpavaenda and Chris Manson and Cliodhna O'Leary and Deela Monji-Patel and A Shodunke and Anthony Dyer and Garry Barton and Amy Dymond",

year = "2017",

language = "English",

note = "European Conference on Neuropsychopharmacology, ECNP ; Conference date: 02-09-2017 Through 05-09-2017",

}

Wyatt, S, Fineberg, N , Irvine, K , Wellsted, D, Baldwin, D, Drummond, L, Hanson, J, Gopi, S, Kaur, S, Reid, J, Marwah, V, Sachdev, R, Pampaloni, I, Shahper, S, Varlakova, Y, Mpavaenda, D, Manson, C, O'Leary, C, Monji-Patel, D, Shodunke, A, Dyer, A, Barton, G & Dymond, A 2017, 'Optimal treatment for OCD (OTO): A randomised controlled feasibility trial comparing the clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder.', European Conference on Neuropsychopharmacology, Paris, France, 2/09/17 - 5/09/17.

Optimal treatment for OCD (OTO): A randomised controlled feasibility trial comparing the clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder. / Wyatt, Solange; Fineberg, Naomi ; Irvine, Karen et al.
2017. Poster session presented at European Conference on Neuropsychopharmacology, Paris, France.

Research output: Contribution to conference › Poster

TY - CONF

T1 - Optimal treatment for OCD (OTO): A randomised controlled feasibility trial comparing the clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder.

AU - Wyatt, Solange

AU - Fineberg, Naomi

AU - Irvine, Karen

AU - Wellsted, David

AU - Baldwin, David

AU - Drummond, Lynne

AU - Hanson, Jasmin

AU - Gopi, Srin

AU - Kaur, Sukhwinder

AU - Reid, Jemma

AU - Marwah, Virender

AU - Sachdev, Ricky

AU - Pampaloni, Ilenia

AU - Shahper, Sonia

AU - Varlakova, Yana

AU - Mpavaenda, Davis

AU - Manson, Chris

AU - O'Leary, Cliodhna

AU - Monji-Patel, Deela

AU - Shodunke, A

AU - Dyer, Anthony

AU - Barton, Garry

AU - Dymond, Amy

N1 - Conference code: 30

PY - 2017

Y1 - 2017

M3 - Poster

T2 - European Conference on Neuropsychopharmacology

Y2 - 2 September 2017 through 5 September 2017

ER -

Wyatt S, Fineberg N , Irvine K , Wellsted D, Baldwin D, Drummond L et al.. Optimal treatment for OCD (OTO): A randomised controlled feasibility trial comparing the clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder.. 2017. Poster session presented at European Conference on Neuropsychopharmacology, Paris, France.